Clinical Trials Directory

Trials / Unknown

UnknownNCT04165603

Fluorescence-navigated Thoracoscopy for Detection of Small Pulmonary Nodules

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
352 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Fluorescence-navigated thoracoscopic imaging with indocyanine green (ICG) is a novel technique for detection of small pulmonary nodules other than traditional radiography or intraoperative palpation. As a non-targeted fluorescent contrast agent, ICG accumulates in tumors by the enhanced permeability and retention effect (EPR), making the lesions fluoresce under fluorescent imaging. However, the optimal dosage and injection time of ICG are still under exploration. Hence, we perform this study in humans made up of four groups to determine the optimal time and dose.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreoperative Infusion of Indocyanine Greenpreoperatively infuse indocyanine green through peripheral vein

Timeline

Start date
2018-12-18
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2019-11-18
Last updated
2019-11-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04165603. Inclusion in this directory is not an endorsement.